10 results
8-K
EX-10.1
ATXI
Avenue Therapeutics Inc
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
Prospectus, as the case may be. As used in this paragraph and elsewhere in this Agreement, “Time of Sale Disclosure Package” means the Preliminary Prospectus … Disclosure Package. The term “any Prospectus” shall mean, as the context requires, the Preliminary Prospectus, the Final Prospectus, and any supplement
8-K
EX-1.1
ATXI
Avenue Therapeutics Inc
12 Oct 22
Avenue Therapeutics Announces Pricing of $12 Million Underwritten Public Offering
9:00am
in the Registration Statement prior to the time at which the Commission declared the Registration Statement effective.
“Pricing Disclosure Package” means … ), the Pricing Disclosure Package, the Final Prospectus (including any amendments or supplements thereto), any Preliminary Prospectus, any Issuer Free Writing
FWP
ATXI
Avenue Therapeutics Inc
6 Oct 22
Free writing prospectus
4:05pm
occupancy BAER - 101 was licensed from AstraZeneca (where it was called AZD7325) in December 2019 with an extensive preclinical and clinical package
15
8-K
EX-1.1
cr6tyg7 dmbncmpua0m3
13 Dec 21
Entry into a Material Definitive Agreement
9:23am
8-K
EX-1.1
by2y quyx
10 Nov 21
Entry into a Material Definitive Agreement
5:22pm
8-K
x74l 0q1b
1 Mar 21
Other Events
7:30am
DEFM14A
xr302r
21 Dec 18
Proxy related to merger
12:23pm
PREM14A
5ps91jpqs1vb xicva
11 Dec 18
Preliminary proxy related to merger
5:23pm
- Prev
- 1
- Next